The American-born pontiff has issued a public plea for peace amid reports of a covert U.S. plan to destabilize Cuba's government, marking his latest critique of Trump-era foreign policy.
As global investment in artificial intelligence infrastructure accelerates, a handful of semiconductor giants stand to reap outsized rewards. We examine the foundational players whose technology is enabling this historic build-out.
Archer-Daniels-Midland (ADM) is set to report Q4 earnings Tuesday morning. Analysts project a slight revenue dip, but investor sentiment remains cautiously optimistic as the agribusiness leader navigates a volatile global market.
All eyes turn to Match Group as it prepares to report Q4 earnings Tuesday afternoon. With analysts forecasting modest revenue growth but lingering concerns over user attrition and profitability, investors brace for another volatile session.
A South Florida couple operating a high-end dealership is accused of using fraudulent invoices to obtain clean titles for rebuilt luxury vehicles, exposing buyers to significant financial risk and prompting a multi-vehicle investigation.
Emily Beutner, a 22-year-old Loyola Marymount University student and daughter of mayoral hopeful Austin Beutner, has died following a medical emergency near a Palmdale highway. The death is under investigation by homicide detectives.
Nvidia is set to make a landmark investment in OpenAI's latest funding round, CEO Jensen Huang confirmed, signaling a deepening alliance between the AI hardware giant and the leading AI research lab. However, reports of internal skepticism at Nvidia introduce uncertainty into the final terms and timing of the deal.
A reported fiery exchange between JPMorgan's Jamie Dimon and Coinbase's Brian Armstrong at the World Economic Forum lays bare the intensifying battle between traditional finance and the crypto industry over regulation, deposits, and the future of money.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
Disney's iconic leader, who returned to steady the company in 2022, is reportedly preparing to exit the CEO role ahead of his contract's expiration, setting the stage for a high-stakes succession search.
The Southern comfort food chain, still reeling from a failed rebrand and customer discontent, now requires traveling staff to eat primarily at its own locations—a move seen as an effort to bolster internal revenue.
President Trump's pick to lead the Federal Reserve, former governor Kevin Warsh, advocates for a dramatic shift in central bank strategy—shrinking its balance sheet—as the key to lowering mortgage rates, a move that challenges prevailing economic orthodoxy.
The Walt Disney Company's board of directors is set to meet next week, with sources indicating a final vote on the long-awaited CEO succession plan is imminent. The decision comes as Bob Iger's contract nears its end and follows a turbulent period of leadership transition at the media giant.
Disney's board is set to convene next week to vote on a successor for CEO Bob Iger, who is now expected to depart before his contract ends in 2026, aiming to give his replacement a 'fresh start'.
Five years after its meme-stock frenzy, GameStop is aiming for a colossal acquisition to transform its business. CEO Ryan Cohen could earn a $35 billion payday if he succeeds in reaching a $100 billion market cap—a goal experts call wildly ambitious.
As Jerome Powell prepares to hand over the reins, his public counsel to a successor underscores the delicate balance between central bank independence and democratic accountability. With Kevin Warsh named as his replacement, the Fed may be poised for a significant shift in philosophy and approach.
President Trump's nominee for Federal Reserve Chair, Kevin Warsh, has championed a 'regime change' at the central bank, focusing on balance sheet reduction and regulatory rollback. However, analysts question his ability to deliver swift interest rate cuts and warn of potential internal conflict.
The financial services sector, a traditional engine of economic growth, is underperforming the S&P 500 amid economic uncertainty. We examine three specific stocks—Invesco, Enova International, and Sixth Street Specialty Lending—that investors may want to approach with heightened caution.
Ovid Therapeutics (NASDAQ: OVID) has garnered analyst optimism following positive Phase 1 trial results for its novel neurological drug candidate and a recent 'Outperform' initiation. The biotech firm is now shifting focus to a more potent oral therapy, with key regulatory milestones ahead.
Sources indicate OpenAI is accelerating plans for a late-2026 public listing, a move that would place its massive cash burn and long road to profitability under intense investor scrutiny, potentially defining the next phase of the AI boom.
